The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of O'donnell Niall since 2019.
This trader's CIK number is 1780235.
At the time of last reporting, O'donnell Niall was the Director of Spruce Biosciences, Inc.. (stock ticker symbol SPRB).
Also see all insider trading activities at Spruce Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | RPHM | 125,000 | $1,000,000 | 0 | $0 | 0 | $0 |
| 2021 | RPHM | 200,000 | $3,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | SPRB | 630,400 | $1,998,368 | 0 | $0 | 0 | $0 |
| 2020 | SPRB | 250,000 | $3,750,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MIRM | 0 | $0 | 300,000 | $5,956,856 | 0 | $0 |
| 2019 | MIRM | 300,000 | $4,500,000 | 0 | $0 | 0 | $0 |
1. Reneo Pharmaceuticals, Inc. (RPHM)
2. Spruce Biosciences, Inc. (SPRB)
3. Mirum Pharmaceuticals, Inc. (MIRM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-05-08 | RPHM | Buy | 125,000 | 8.00 | 1,000,000 |
| 2021-04-13 | RPHM | Buy | 200,000 | 15.00 | 3,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-02-16 | SPRB | Buy | 630,400 | 3.17 | 1,998,368 |
| 2020-10-14 | SPRB | Buy | 250,000 | 15.00 | 3,750,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-14 | MIRM | Sale | 32,109 | 19.60 | 629,432 |
| 2022-11-11 | MIRM | Sale | 174,121 | 19.99 | 3,481,375 |
| 2022-11-15 | MIRM | Sale | 93,770 | 19.69 | 1,846,049 |
| 2019-07-22 | MIRM | Buy | 300,000 | 15.00 | 4,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'donnell Niall (Director of Spruce Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.